🦊/Investors

BAM Elevate

Institutional investor

Chicago · 2 people tracked

Also known as BALYASNY ASSET MANAGEMENT L.P.

Find your way into BAM Elevate

1 people in our graph share verified history with the BAM Elevate team — schools, employers, funds. One of them is your warm intro.

Fox Verdict
Sign up to see your fit

Investment thesis

Balyasny generates absolute returns in all markets through a blend of core strategies driven by proprietary research. The firm emphasizes bringing together talented teams and business builders to create winning organizations that iterate and improve. The firm's philosophy centers on identifying problems, solving them directly, and maintaining humility while constantly learning and evolving. Partnership is foundational to the firm's approach, both internally across strategies and departments and externally with investors and portfolio partners.

Invests inSector AgnosticChicagoGlobal

Source: firm website, verified Sep 20, 2026.

HQ
Chicago, CA, US
Leads rounds
Follows
Instruments
Equity
Founded
2001
Last 12 months
8 investments
AUM
$248.1B
Tracked investments
18
Unicorns
2
IPOs
1

Team · 2 people

from the firm's website & public directories

What they invest in

from 16 of 18 portfolio companies

AI & Machine Learning ×7Enterprise Software ×5SaaS ×5Fintech ×4Biotech ×3Data & Infrastructure ×2Deep Tech ×2Defense Tech ×2

HQs:United States×10

Investments · 19 tracked

founders shown can be your intro path

By year:2026 · 62025 · 22024 · 22023 · 22022 · 618 dated

Damora TherapeuticsNASDAQ: DMRANov 2025 · $284.9M

Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.

BiotechCopenhagen, US

Garrett Winslow(Executive Officer)inLori Firmani(Executive Officer)inHans T. Schambye(Executive Officer, Director)Jennifer Jarrett(President, Chief Executive Officer and Director)inBecker Hewes(Chief Medical Officer)Sherwin Sattarzadeh(Chief Operating Officer)

Co-investorsAccess BiotechnologyBay City CapitalCommodore CapitalEIR VenturesForbionJanus Henderson Investors+6 more

Relmada Therapeuticsrelmada.comNASDAQ: RLMDMar 2026

Relmada is a clinical-stage biopharmaceutical company developing therapies including NDV-01, a sustained-release intravesical formulation of gemcitabine and docetaxel for non-muscle invasive bladder cancer, and Sepranolone, a candidate targeting compulsive behaviors via GABAA receptor modulation.

BiotechHealthtechNew York, US

Sergio Traversa(Executive Officer, Director)Paul Kelly(Director)Maged Shenouda(Director)inEliseo O. Salinas(President and Chief Scientific Officer)inDouglas Beck(Chief Financial Officer)Charles Ence(Chief Accounting and Compliance Officer)

Co-investorsBioAdvanceBraidwellCommodore CapitalJanus Henderson InvestorsOrbiMedRA Capital+2 more

AI for software developmentpoolside.aiOct 2024 · $500M

Poolside builds open-weight foundation models and agentic coding models, including the Laguna family, along with the systems and infrastructure needed to train, refine, and improve these models.

AI & Machine LearningDeveloper Tools

Jason Warner(Founder & CEO)inEiso Kant(Founder)

Co-investors7GC & CoAbstraction CapitalAir Street CapitalB Capital GroupB4 CapitalBain Capital Ventures+24 more

Arthurarthur.digitalin𝕏Sep 2022 · $42M

Arthur develops an AI-powered platform that enables organizations to build and deploy immersive workflows and experiences combining synchronous and asynchronous collaboration.

AI & Machine LearningEnterprise SoftwareFuture of Work

Christoph Fleischmann(Founder)in

Co-investorsDraper AssociatesAcrew CapitalGreycroftHomebrewIndex VenturesPlexo Capital+1 more

Astranisastranis.comin𝕏May 2026 · $300M

Astranis manufactures small, high-powered geosynchronous satellites equipped with advanced digital processing technology for global telecommunications and connectivity services.

Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US

John Gedmark(Founder/CEO)inRyan McLinko(Founder/CTO)in

Co-investorsAndreessen HorowitzBlack FlagBoxGroupCantos VenturesCherubic VenturesCommonweal Ventures+39 more

Coultreoncoultreon.cominApr 2026 · $125M

Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.

AI & Machine LearningBiotech

Pierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMarie De Vulder(Chief Legal Officer Co-founder)inGuy Peeters(Chief Financial Officer Co-founder)inJohn-Paul Gallivan(Head of Development Co-founder)inFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in

Co-investorsLongwood FundSofinnova VenturesFinchley Healthcare VenturesForbionLuma GroupNovo Holdings+1 more

Edge Deltaedgedelta.comin𝕏May 2022 · $63M

Edge Delta provides telemetry pipeline and observability tools for DevOps, IT/Ops, SRE, and Security teams to process logs, metrics, traces, and events at scale without centralizing all raw data.

AI & Machine LearningData & InfrastructureDeveloper ToolsEnterprise SoftwareSeattle, US

Ozan Unlu(Co-founder)inFatih Yildiz(Co-founder)in

Co-investorsAmity VenturesCisco InvestmentsGeodesic CapitalMaC Venture CapitalMenlo VenturesCisco+2 more

Forterraforterra.comin𝕏Nov 2025 · $238M

Forterra develops autonomous weapons, sensors, and battlefield systems using distributed control networks for defense operations.

AI & Machine LearningDefense TechRobotics

Alberto Lacaze(Chairman of the Board and President)inJoseph Putney(Chief Technology Officer)in

Co-investors645 VenturesCRESCENT COVE CAPITALEnlightenment CapitalGlynn Capital ManagementNightDragonSalesforce Ventures+8 more

Harnessgoharness.comApr 2022

Harness is a fundraising platform designed for nonprofits to increase donation revenue without expanding staff or software tools.

FintechImpact & Social GoodSaaS

Jyoti Bansal(Founder)in

Co-investorsFlorida FundersAlkeon CapitalBattery VenturesCapital One VenturesCiti VenturesGaingels+8 more

Harnessharnessfi.cominApr 2022

Harness turns financial institutions' raw transaction and member data into real-time, personalized engagement campaigns for card and rewards programs.

Data & InfrastructureFintechMarketing Tech

Co-investorsTruStage VenturesAlkeon CapitalBattery VenturesCapital One VenturesCiti VenturesDeepgram+9 more

Instrumentalinstrumental.financeinFeb 2022 · $50M

Strategy hub enabling DeFi yield access across multiple chains and layers for comprehensive cross-chain growth.

Co-investorsAdvanced BlockchainEclipse VenturesRoot Ventures

Leapleap.energyinJun 2023 · $15M

Leap builds a platform that enables virtual power plant management by connecting storage, electric vehicle, and smart building systems to grid-support energy programs, helping reduce fossil fuel dependence and integrate renewable energy.

AI & Machine LearningCleantechClimate TechEnergySaaSSan Francisco, US

Remco van den Elzen(Co-founder, Leap)inTHOMAS FOLKER(Executive Officer, Director, Promoter)inThomas Folker(Co-Founder, Chief Strategy Officer)inNICK GROSSMAN(Director)inJason Michaels(CEO)in

Co-investorsCongruent VenturesPresidio VenturesNational Grid PartnersGaruda VenturesLightbankUnion Square Ventures (USV)+6 more

Leapleap.expertin𝕏Jun 2023 · $15M

LeapXpert provides enterprise governance and security controls for messaging platforms, enabling organizations to enforce data loss prevention, information barriers, and compliance policies across channels like Teams and Slack.

CybersecurityEnterprise SoftwareFintechGovTechSaaS

Co-investorsQBN CapitalApis PartnersCostanoa VenturesEqual VenturesJungle VenturesOwl Ventures+1 more

Logiwalogiwa.cominNov 2022

Logiwa IO is a cloud-native warehouse management system designed for third-party logistics providers and fulfillment networks that process high volumes of orders.

AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaSChicago, US

Erhan Musaoglu(CEO)inGreg Halko(COO)inPatrick Bouchard(CRO)in

Co-investorsLaunchCapitalNewRoad Capital Partners, LLCRunway Venture PartnersSpider CapitalLaunch CapitalPrologis Ventures

Lycia Therapeuticslyciatx.comin𝕏Jun 2026 · $75M

Lycia Therapeutics is a biotechnology company developing LYTAC (Lysosomal Targeting Chimera) therapeutics that bind disease-causing extracellular and cell-surface proteins and route them into the cell's lysosome for degradation.

BiotechHealthtechSouth San Francisco, US

Aetna Wun Trombley(President and CEO)inAmy Bachrodt(Chief Financial Officer)inChin Lee(Chief Medical Officer)inSteve Staben(Chief Scientific Officer)inSofia Touami(Chief Business Officer)inKaren Flick(General Counsel)in

Co-investorsREDMILEVersant VenturesFranklin TempletonHBM Healthcare InvestmentsInvusJanus Henderson Investors+4 more

Skyryseskyryse.comin𝕏Feb 2026

Skyryse develops SkyOS, a flight-control operating system that simplifies aircraft operation through automated maneuvers, emergency management, and optionally piloted or autonomous flight.

Deep TechDefense TechMobility & TransportationEl Segundo, US

Mark Groden(Founder & CEO)inStephen Koo(Executive Officer, Director)inBlake Bilstad(Executive Officer)in

BoardLior Susan(Director)inWill Summerlin(Director)Ethan Batraski(Director)in

Co-investorsCantos VenturesCity LightDas & Co.Embedded VenturesFlucas VenturesFontinalis Partners+18 more

The Honest Companyhonest.comAug 2026

Honest is a consumer brand offering personal care and baby products made with ingredients audited by toxicologists and tested by dermatologists, formulated without synthetic fragrances and marketed as cruelty-free.

ConsumerDirect to ConsumerWellness & FitnessSanta Monica, US

Christopher Gavigan(Executive Officer, Promoter)Brian Lee(Executive Officer, Director, Promoter)inSean Kane(Executive Officer)inJessica Alba(Founder)inCraig Gatarz(Executive Officer)David Parker(Executive Officer)

Co-investorsFarvatn VentureICONIQIVP (Institutional Venture Partners)Lightspeed Venture PartnersMisfit Venture PartnersSfventures Group LLC+2 more

Treasury Primetreasuryprime.comin𝕏

Treasury Prime provides embedded banking technology through APIs that enable fintechs to embed banking services in their applications.

Enterprise SoftwareFintechSaaSSan Francisco, US

Chris Dean(Founder/CEO)inJim Brusstar(Founder)in

Co-investorsArdent VentureAZURO CAPITAL VENTURESDeciensFINTOP CapitalGMO VenturePartnersNyca+3 more

Exits · 1

1 IPOs

Damora TherapeuticsNASDAQ: DMRARelmada TherapeuticsNASDAQ: RLMD

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has BAM Elevate made?
BAM Elevate has 18 tracked investments, 1 of which have exited, including 9 dated in the last 24 months.
What sectors does BAM Elevate focus on?
BAM Elevate focuses on Sector Agnostic.
Where is BAM Elevate located?
BAM Elevate is headquartered in Chicago, US.
Does BAM Elevate lead rounds?
BAM Elevate typically participates in rounds rather than leading them.

Similar investors

3TS Capital Partners

3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.

$324K – $10.8M
4Di Capital

4DI Ventures was co-founded by repeat tech operator and ESET Southern Africa founder Justin Stanford, giving it unusually deep cybersecurity and software operating experience rather than a purely financial background, and originated from Stanford's own angel-investing experiments that directly led to both the firm's creation and the launch of the Silicon Cape Initiative. The firm explicitly describes its style as "nurture capital" with intensive, hands-on engagement, and Stanford is vocal about avoiding the "unicorn at all costs" mentality in African tech, instead emphasizing sustainable market readiness and fundamentals in a more conservative, durability-focused investment approach.

$100K – $1M
83North

83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.

$100K – $10M
8VC

8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.

$100K – $50M
Accel

Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.

$1.6M – $70M

Featured in lists